APA

Voloshin T., Kaynan N., Davidi S., Porat Y., Shteingauz A., Schneiderman R. S., Zeevi E., Munster M., Blat R., Tempel Brami C., Cahal S., Itzhaki A., Giladi M., Kirson E. D., Weinberg U., Kinzel A. & Palti Y. (20200630). Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy. : Cancer immunology, immunotherapy : CII.

Chicago

Voloshin Tali, Kaynan Noa, Davidi Shiri, Porat Yaara, Shteingauz Anna, Schneiderman Rosa S, Zeevi Einav, Munster Mijal, Blat Roni, Tempel Brami Catherine, Cahal Shay, Itzhaki Aviran, Giladi Moshe, Kirson Eilon D, Weinberg Uri, Kinzel Adrian and Palti Yoram. 20200630. Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy. : Cancer immunology, immunotherapy : CII.

Harvard

Voloshin T., Kaynan N., Davidi S., Porat Y., Shteingauz A., Schneiderman R. S., Zeevi E., Munster M., Blat R., Tempel Brami C., Cahal S., Itzhaki A., Giladi M., Kirson E. D., Weinberg U., Kinzel A. and Palti Y. (20200630). Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy. : Cancer immunology, immunotherapy : CII.

MLA

Voloshin Tali, Kaynan Noa, Davidi Shiri, Porat Yaara, Shteingauz Anna, Schneiderman Rosa S, Zeevi Einav, Munster Mijal, Blat Roni, Tempel Brami Catherine, Cahal Shay, Itzhaki Aviran, Giladi Moshe, Kirson Eilon D, Weinberg Uri, Kinzel Adrian and Palti Yoram. Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy. : Cancer immunology, immunotherapy : CII. 20200630.